StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3027% below fair value
$2.60+0.00 (0.00%)

Close on Nov 17, 2026Market cap $148.68MP/E –Yield –

Abeona Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Abeona Therapeutics's gross margin for the twelve months ending Jun 30, 2026 was 67.1%. For fiscal 2025 it was 73.7%, against 100.0% the year before. The highest annual figure on record is 100.0% in fiscal 2014.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202573.7%−26.3
FY2014Dec 31, 2014100.0%+6.1
FY2013Dec 31, 201393.9%−0.1
FY2012Dec 31, 201293.9%+2.0
FY2011Dec 31, 201192.0%+21.1
FY2010Dec 31, 201070.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202663.3%–
Q1 FY2026Mar 31, 202669.1%–
Q4 FY2025Dec 31, 202580.7%–

More Abeona Therapeutics figures

See a number that looks wrong?